-
1
-
-
33750374233
-
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
-
Zhang W., Doherty M., Pascual E., Bardin T., Barskova V., Conaghan P., et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 65 (2006) 1301-1311
-
(2006)
Ann. Rheum. Dis.
, vol.65
, pp. 1301-1311
-
-
Zhang, W.1
Doherty, M.2
Pascual, E.3
Bardin, T.4
Barskova, V.5
Conaghan, P.6
-
2
-
-
33748608331
-
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
-
Zhang W., Doherty M., Bardin T., Pascual E., Barskova V., Conaghan P., et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 65 (2006) 1312-1324
-
(2006)
Ann. Rheum. Dis.
, vol.65
, pp. 1312-1324
-
-
Zhang, W.1
Doherty, M.2
Bardin, T.3
Pascual, E.4
Barskova, V.5
Conaghan, P.6
-
3
-
-
1942471074
-
Alcohol intake and risk of incident gout in men: a prospective study
-
Choi H.K., Atkinson K., Karlson E.W., Willett W., and Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363 (2004) 1277-1281
-
(2004)
Lancet
, vol.363
, pp. 1277-1281
-
-
Choi, H.K.1
Atkinson, K.2
Karlson, E.W.3
Willett, W.4
Curhan, G.5
-
5
-
-
12344327218
-
Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey
-
Choi H.K., Liu S., and Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 52 (2005) 283-289
-
(2005)
Arthritis Rheum.
, vol.52
, pp. 283-289
-
-
Choi, H.K.1
Liu, S.2
Curhan, G.3
-
6
-
-
17644371344
-
Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study
-
Choi H.K., Atkinson K., Karlson E.W., and Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch. Intern. Med. 165 (2005) 742-748
-
(2005)
Arch. Intern. Med.
, vol.165
, pp. 742-748
-
-
Choi, H.K.1
Atkinson, K.2
Karlson, E.W.3
Curhan, G.4
-
7
-
-
1542316154
-
Purine-rich foods, dairy and protein intake, and the risk of gout in men
-
Choi H.K., Atkinson K., Karlson E.W., Willett W., and Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N. Engl. J. Med. 350 (2004) 1093-1103
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 1093-1103
-
-
Choi, H.K.1
Atkinson, K.2
Karlson, E.W.3
Willett, W.4
Curhan, G.5
-
8
-
-
31544454981
-
The prevalence of metabolic syndrome in patients with gout: a multicenter study
-
Rho Y.H., Choi S.J., Lee Y.H., Ji J.D., Choi K.M., Baik S.H., et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J. Korean Med. Sci. 20 (2005) 1029-1033
-
(2005)
J. Korean Med. Sci.
, vol.20
, pp. 1029-1033
-
-
Rho, Y.H.1
Choi, S.J.2
Lee, Y.H.3
Ji, J.D.4
Choi, K.M.5
Baik, S.H.6
-
9
-
-
0037809650
-
Fenofibrate and losartan
-
Bardin T. Fenofibrate and losartan. Ann. Rheum. Dis. 62 (2003) 497-498
-
(2003)
Ann. Rheum. Dis.
, vol.62
, pp. 497-498
-
-
Bardin, T.1
-
11
-
-
0043182879
-
Does colchicine work? The results of the first controlled study in acute gout
-
Ahern M.J., Reid C., Gordon T.P., McCredie M., Brooks P.M., and Jones M. Does colchicine work? The results of the first controlled study in acute gout. Aust. N. Z. J. Med. 17 (1987) 301-304
-
(1987)
Aust. N. Z. J. Med.
, vol.17
, pp. 301-304
-
-
Ahern, M.J.1
Reid, C.2
Gordon, T.P.3
McCredie, M.4
Brooks, P.M.5
Jones, M.6
-
12
-
-
33847196892
-
Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies
-
(in press)
-
Bingham III C.O., Sebba A.I., Rubin B.R., Ruoff G.E., Kremer J., Bird S., et al. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford) (2006) (in press)
-
(2006)
Rheumatology (Oxford)
-
-
Bingham III, C.O.1
Sebba, A.I.2
Rubin, B.R.3
Ruoff, G.E.4
Kremer, J.5
Bird, S.6
-
13
-
-
0036158391
-
Local ice therapy during bouts of acute gouty arthritis
-
Schlesinger N., Detry M.A., Holland B.K., Baker D.G., Beutler A.M., Rull M., et al. Local ice therapy during bouts of acute gouty arthritis. J. Rheumatol. 29 (2002) 331-334
-
(2002)
J. Rheumatol.
, vol.29
, pp. 331-334
-
-
Schlesinger, N.1
Detry, M.A.2
Holland, B.K.3
Baker, D.G.4
Beutler, A.M.5
Rull, M.6
-
14
-
-
33845473516
-
Response to application of ice may help differentiate between gouty arthritis and other inflammatory arthritides
-
Schlesinger N. Response to application of ice may help differentiate between gouty arthritis and other inflammatory arthritides. J Clin Rheumatol 12 (2006) 275-276
-
(2006)
J Clin Rheumatol
, vol.12
, pp. 275-276
-
-
Schlesinger, N.1
-
15
-
-
0032853025
-
Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide
-
Fernandez C., Noguera R., Gonzalez J.A., and Pascual E. Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide. J. Rheumatol. 26 (1999) 2285-2286
-
(1999)
J. Rheumatol.
, vol.26
, pp. 2285-2286
-
-
Fernandez, C.1
Noguera, R.2
Gonzalez, J.A.3
Pascual, E.4
-
16
-
-
0030001513
-
Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs
-
Werlen D., Gabay C., and Vischer T.L. Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs. Rev. Rhum. Engl. Ed 63 (1996) 248-254
-
(1996)
Rev. Rhum. Engl. Ed
, vol.63
, pp. 248-254
-
-
Werlen, D.1
Gabay, C.2
Vischer, T.L.3
-
17
-
-
0028133477
-
Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis
-
Siegel L.B., Alloway J.A., and Nashel D.J. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. J. Rheumatol. 21 (1994) 1325-1327
-
(1994)
J. Rheumatol.
, vol.21
, pp. 1325-1327
-
-
Siegel, L.B.1
Alloway, J.A.2
Nashel, D.J.3
-
18
-
-
27144533642
-
Allopurinol-induced DRESS syndrome
-
Markel A. Allopurinol-induced DRESS syndrome. Isr. Med. Assoc. J. 7 (2005) 656-660
-
(2005)
Isr. Med. Assoc. J.
, vol.7
, pp. 656-660
-
-
Markel, A.1
-
19
-
-
33746165113
-
Gout in renal transplant recipients
-
Stamp L., Ha L., Searle M., O'Donnell J., Frampton C., and Chapman P. Gout in renal transplant recipients. Nephrology (Carlton) 11 (2006) 367-371
-
(2006)
Nephrology (Carlton)
, vol.11
, pp. 367-371
-
-
Stamp, L.1
Ha, L.2
Searle, M.3
O'Donnell, J.4
Frampton, C.5
Chapman, P.6
-
20
-
-
33750428244
-
Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients
-
Torres R.J., Prior C., and Puig J.G. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients. Nucleosides Nucleotides Nucleic Acids 25 (2006) 1077-1082
-
(2006)
Nucleosides Nucleotides Nucleic Acids
, vol.25
, pp. 1077-1082
-
-
Torres, R.J.1
Prior, C.2
Puig, J.G.3
-
21
-
-
17644375873
-
Clinical heterogeneity of drug hypersensitivity
-
Roujeau J.C. Clinical heterogeneity of drug hypersensitivity. Toxicology 209 (2005) 123-129
-
(2005)
Toxicology
, vol.209
, pp. 123-129
-
-
Roujeau, J.C.1
-
22
-
-
0031662935
-
Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout
-
Perez-Ruiz F., Alonso-Ruiz A., Calabozo M., Herrero-Beites A., Garcia-Erauskin G., and Ruiz-Lucea E. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. Ann. Rheum. Dis. 57 (1998) 545-549
-
(1998)
Ann. Rheum. Dis.
, vol.57
, pp. 545-549
-
-
Perez-Ruiz, F.1
Alonso-Ruiz, A.2
Calabozo, M.3
Herrero-Beites, A.4
Garcia-Erauskin, G.5
Ruiz-Lucea, E.6
-
23
-
-
0033668058
-
Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts
-
Perez-Ruiz F., Calabozo M., Herrero-Beites A.M., Garcia-Erauskin G., and Pijoan J.I. Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 86 (2000) 287-291
-
(2000)
Nephron
, vol.86
, pp. 287-291
-
-
Perez-Ruiz, F.1
Calabozo, M.2
Herrero-Beites, A.M.3
Garcia-Erauskin, G.4
Pijoan, J.I.5
-
24
-
-
33847187129
-
Probenecid (benemid): its uses and side-effects in 2,502 patients
-
Boger W.P., and Strickland S.C. Probenecid (benemid): its uses and side-effects in 2,502 patients. AMA Arch. Intern. Med. 95 (1955) 83-92
-
(1955)
AMA Arch. Intern. Med.
, vol.95
, pp. 83-92
-
-
Boger, W.P.1
Strickland, S.C.2
-
25
-
-
0017720265
-
Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia
-
Heel R.C., Brogden R.N., Speight T.M., and Avery G.S. Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia. Drugs 14 (1977) 349-366
-
(1977)
Drugs
, vol.14
, pp. 349-366
-
-
Heel, R.C.1
Brogden, R.N.2
Speight, T.M.3
Avery, G.S.4
-
26
-
-
0019501056
-
Ten years' experience with benzbromarone in the management of gout and hyperuricaemia
-
Masbernard A., and Giudicelli C.P. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia. S. Afr. Med. J. 59 (1981) 701-706
-
(1981)
S. Afr. Med. J.
, vol.59
, pp. 701-706
-
-
Masbernard, A.1
Giudicelli, C.P.2
-
27
-
-
26944437126
-
Benzbromarone therapy in management of refractory gout
-
Kumar S., Ng J., and Gow P. Benzbromarone therapy in management of refractory gout. N. Z. Med. J. 118 (2005) U1528
-
(2005)
N. Z. Med. J.
, vol.118
-
-
Kumar, S.1
Ng, J.2
Gow, P.3
-
28
-
-
0016929629
-
Clinical evaluation of benzbromarone: a new uricosuric drug
-
Sorensen L.B., and Levinson D.J. Clinical evaluation of benzbromarone: a new uricosuric drug. Arthritis Rheum. 19 (1976) 183-190
-
(1976)
Arthritis Rheum.
, vol.19
, pp. 183-190
-
-
Sorensen, L.B.1
Levinson, D.J.2
-
29
-
-
85047698010
-
Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study
-
Zurcher R.M., Bock H.A., and Thiel G. Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study. Nephrol. Dial. Transplant. 9 (1994) 548-551
-
(1994)
Nephrol. Dial. Transplant.
, vol.9
, pp. 548-551
-
-
Zurcher, R.M.1
Bock, H.A.2
Thiel, G.3
-
30
-
-
33744963408
-
Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol
-
(quiz 343)
-
Richette P., and Bardin T. Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol. Nat. Clin. Pract. Rheumatol. 2 (2006) 338-342 (quiz 343)
-
(2006)
Nat. Clin. Pract. Rheumatol.
, vol.2
, pp. 338-342
-
-
Richette, P.1
Bardin, T.2
-
31
-
-
30744449541
-
Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases
-
Ka T., Inokuchi T., Tsutsumi Z., Takahashi S., Moriwaki Y., and Yamamoto T. Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases. Int. J. Clin. Pharmacol. Ther. 44 (2006) 22-26
-
(2006)
Int. J. Clin. Pharmacol. Ther.
, vol.44
, pp. 22-26
-
-
Ka, T.1
Inokuchi, T.2
Tsutsumi, Z.3
Takahashi, S.4
Moriwaki, Y.5
Yamamoto, T.6
-
32
-
-
0023905821
-
Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial
-
Bastow M.D., Durrington P.N., and Ishola M. Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial. Metabolism 37 (1988) 217-220
-
(1988)
Metabolism
, vol.37
, pp. 217-220
-
-
Bastow, M.D.1
Durrington, P.N.2
Ishola, M.3
-
33
-
-
33748415886
-
Effect of fenofibrate in combination with urate lowering agents in patients with gout
-
Lee Y.H., Lee C.H., and Lee J. Effect of fenofibrate in combination with urate lowering agents in patients with gout. Korean J. Intern. Med. 21 (2006) 89-93
-
(2006)
Korean J. Intern. Med.
, vol.21
, pp. 89-93
-
-
Lee, Y.H.1
Lee, C.H.2
Lee, J.3
-
34
-
-
0038325699
-
Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism
-
Takahashi S., Moriwaki Y., Yamamoto T., Tsutsumi Z., Ka T., and Fukuchi M. Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism. Ann. Rheum. Dis. 62 (2003) 572-575
-
(2003)
Ann. Rheum. Dis.
, vol.62
, pp. 572-575
-
-
Takahashi, S.1
Moriwaki, Y.2
Yamamoto, T.3
Tsutsumi, Z.4
Ka, T.5
Fukuchi, M.6
-
35
-
-
0042073189
-
Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis
-
Perez-Ruiz F., and Nolla J.M. Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis. J Clin Rheumatol 9 (2003) 215-218
-
(2003)
J Clin Rheumatol
, vol.9
, pp. 215-218
-
-
Perez-Ruiz, F.1
Nolla, J.M.2
-
36
-
-
14944345365
-
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout
-
Becker M.A., Schumacher Jr. H.R., Wortmann R.L., MacDonald P.A., Palo W.A., Eustace D., et al. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum. 52 (2005) 916-923
-
(2005)
Arthritis Rheum.
, vol.52
, pp. 916-923
-
-
Becker, M.A.1
Schumacher Jr., H.R.2
Wortmann, R.L.3
MacDonald, P.A.4
Palo, W.A.5
Eustace, D.6
-
37
-
-
28944437578
-
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
-
Becker M.A., Schumacher Jr. H.R., Wortmann R.L., MacDonald P.A., Eustace D., Palo W.A., et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N. Engl. J. Med. 353 (2005) 2450-2461
-
(2005)
N. Engl. J. Med.
, vol.353
, pp. 2450-2461
-
-
Becker, M.A.1
Schumacher Jr., H.R.2
Wortmann, R.L.3
MacDonald, P.A.4
Eustace, D.5
Palo, W.A.6
-
38
-
-
17144396355
-
Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment
-
Mayer M.D., Khosravan R., Vernillet L., Wu J.T., Joseph-Ridge N., and Mulford D.J. Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment. Am. J. Ther. 12 (2005) 22-34
-
(2005)
Am. J. Ther.
, vol.12
, pp. 22-34
-
-
Mayer, M.D.1
Khosravan, R.2
Vernillet, L.3
Wu, J.T.4
Joseph-Ridge, N.5
Mulford, D.J.6
-
39
-
-
29644447615
-
The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase
-
Khosravan R., Grabowski B.A., Mayer M.D., Wu J.T., Joseph-Ridge N., and Vernillet L. The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase. J. Clin. Pharmacol. 46 (2006) 88-102
-
(2006)
J. Clin. Pharmacol.
, vol.46
, pp. 88-102
-
-
Khosravan, R.1
Grabowski, B.A.2
Mayer, M.D.3
Wu, J.T.4
Joseph-Ridge, N.5
Vernillet, L.6
-
40
-
-
33746995205
-
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
-
Ganson N.J., Kelly S.J., Scarlett E., Sundy J.S., and Hershfield M.S. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase. Arthritis Res. Ther. 8 (2006) R12
-
(2006)
Arthritis Res. Ther.
, vol.8
-
-
Ganson, N.J.1
Kelly, S.J.2
Scarlett, E.3
Sundy, J.S.4
Hershfield, M.S.5
-
41
-
-
10044275104
-
Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis
-
Borstad G.C., Bryant L.R., Abel M.P., Scroggie D.A., Harris M.D., and Alloway J.A. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J. Rheumatol. 31 (2004) 2429-2432
-
(2004)
J. Rheumatol.
, vol.31
, pp. 2429-2432
-
-
Borstad, G.C.1
Bryant, L.R.2
Abel, M.P.3
Scroggie, D.A.4
Harris, M.D.5
Alloway, J.A.6
-
42
-
-
33750022818
-
The management of gout at an academic healthcare center in Beijing: a physician survey
-
Fang W., Zeng X., Li M., Chen L.X., Schumacher Jr. H.R., and Zhang F. The management of gout at an academic healthcare center in Beijing: a physician survey. J. Rheumatol. 33 (2006) 2041-2049
-
(2006)
J. Rheumatol.
, vol.33
, pp. 2041-2049
-
-
Fang, W.1
Zeng, X.2
Li, M.3
Chen, L.X.4
Schumacher Jr., H.R.5
Zhang, F.6
-
43
-
-
33745610176
-
Gout medication treatment patterns and adherence to standards of care from a managed care perspective
-
Sarawate C.A., Brewer K.K., Yang W., Patel P.A., Schumacher H.R., Saag K.G., et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin. Proc. 81 (2006) 925-934
-
(2006)
Mayo Clin. Proc.
, vol.81
, pp. 925-934
-
-
Sarawate, C.A.1
Brewer, K.K.2
Yang, W.3
Patel, P.A.4
Schumacher, H.R.5
Saag, K.G.6
|